Upgrade to SI Premium - Free Trial

Biogen's Empaveli cuts proteinuria 75% in teens with rare kidney disease

September 17, 2026 4:15 PM
Biogen Inc. (Nasdaq: BIIB) announced the publication of results from a prespecified adolescent subgroup analysis ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA